ClariVest Asset Management’s Neurocrine Biosciences NBIX Stock Holding History

ClariVest Asset Management’s Portfolio NBIX Stock Details NBIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$1.32M	Hold	9,613	–	–	0.14%	207
2024 Q2	$1.32M	Buy	9,613 +19	+0.2%	+$2.61K	0.14%	207
2024 Q1	$1.32M	Sell	9,594 -79	-0.8%	-$10.8K	0.14%	216
2023 Q4	$1.27M	Sell	9,673 -3	-0%	-$345	0.07%	208
2023 Q3	$1.09M	Buy	9,676 +15	+0.2%	+$1.58K	0.06%	222
2023 Q2	$911K	Sell	9,661 -2,004	-17%	-$196K	0.05%	261
2023 Q1	$1.18M	Sell	11,665 -12	-0.1%	-$1.25K	0.05%	261
2022 Q4	$1.4M	Sell	11,677 -44	-0.4%	-$5.15K	0.07%	225
2022 Q3	$1.25M	Sell	11,721 -3,639	-24%	-$369K	0.06%	231
2022 Q2	$1.5M	Sell	15,360 -4,000	-21%	-$369K	0.07%	226
2022 Q1	$1.81M	Hold	19,360	–	–	0.07%	222
2021 Q4	$1.65M	Sell	19,360 -1,900	-9%	-$175K	0.05%	255
2021 Q3	$2.04M	Sell	21,260 -500	-2%	-$47.2K	0.07%	231
2021 Q2	$2.12M	Hold	21,760	–	–	0.07%	213
2021 Q1	$2.12M	Sell	21,760 -200	-0.9%	-$21K	0.07%	201
2020 Q4	$2.1M	Sell	21,960 -200	-0.9%	-$19.3K	0.07%	211
2020 Q3	$2.13M	Sell	22,160 -460	-2%	-$53.2K	0.07%	216
2020 Q2	$2.76M	Buy	22,620 +12,020	+113%	+$1.33M	0.08%	187
2020 Q1	$918K	Buy	+10,600	New	+$1.04M	0.03%	313
2018 Q2	–	Sell	-14,015	Closed	-$1.16M	–	756
2018 Q1	$1.16M	Buy	14,015 +100	+0.7%	+$8.45K	0.02%	407
2017 Q4	$1.08M	Sell	13,915 -15,398	-53%	-$1.05M	0.02%	416
2017 Q3	$1.8M	Hold	29,313	–	–	0.04%	298
2017 Q2	$1.35M	Sell	29,313 -20	-0.1%	-$970	0.03%	317
2017 Q1	$1.27M	Hold	29,333	–	–	0.03%	318
2016 Q4	$1.14M	Sell	29,333 -29	-0.1%	-$1.31K	0.03%	321
2016 Q3	$1.49M	Sell	29,362 -10,339	-26%	-$515K	0.04%	252
2016 Q2	$1.8M	Buy	39,701 +5,300	+15%	+$244K	0.05%	225
2016 Q1	$1.36M	Buy	34,401 +1,332	+4%	+$52.9K	0.04%	250
2015 Q4	$1.87M	Buy	33,069 +8,600	+35%	+$437K	0.05%	200
2015 Q3	$974K	Sell	24,469 -600	-2%	-$29K	0.03%	278
2015 Q2	$1.2M	Buy	25,069 +10,397	+71%	+$441K	0.04%	267
2015 Q1	$582K	Buy	+14,672	New	+$525K	0.02%	329